Yesterday we had the honor of attending the award ceremony for the new Miquel Rutllant Fellowships 2025, where the awardees from the 2024 call were invited to present the progress of their projects during the first year of funding. Representing ULAB, we presented the advances of our project entitled “Precision nano-immunotherapy against CXCR4+ leukemic stem cells in Acute Myeloid Leukemia.”
The event was attended by members of the Fundació Salut i Progress, the Deputy Director General for Research of the Generalitat de Catalunya, Eva Pérez Gabucio, and the family members of Miquel Rutllant.
We are grateful for the opportunity to share the progress of our research and for the continued support of initiatives that promote advances in leukemia research